Authors

  • Igamberdieva R.Sh.

Keywords:

atrial fibrillation, chronic kidney disease, thromboembolic complications, anticoagulant therapy.

References

Jones A, Patel K, Smith T. Anticoagulation in chronic kidney disease: current status. J Thromb Haemost. 2023;21(11):2857-2871. doi:10.1111/jth.16497

Lee SR, Choi EK, Park CS, et al. Renal outcomes of rivaroxaban compared with warfarin in Korean patients with atrial fibrillation. Kidney Res Clin Pract. 2023;42(1):51-63. doi:10.23876/j.krcp.22.099

Lee WC, Fang CY, Hsieh MJ, et al. The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients. Thromb J. 2021;19(1):78. doi:10.1186/s12959-021-00351-1

Mezue K, Gopal DM, Reddy VY. Anticoagulation-related nephropathy for the internist. Cleve Clin J Med. 2020;87(11):663-670. doi:10.3949/ccjm.87a.20044

Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-891. doi:10.1056/NEJMoa1009638

Sitticharoenchai P, Chaikriangkrai K, Srivali N, et al. Non–Vitamin K antagonist oral anticoagulants provide lower risk of acute kidney injury and end-stage renal disease compared with warfarin. J Am Heart Assoc. 2021;10(13):e019609. doi:10.1161/JAHA.120.019609

Vestergaard AEF, Adelborg K, Skjøth F, et al. Oral anticoagulant treatment and risk of kidney disease: a population-based study. Clin Kidney J. 2024;17(1):sfad252. doi:10.1093/ckj/sfad252

Wheeler DS, Giugliano RP, Rangaswami J. Anticoagulation-related nephropathy. J Am Coll Cardiol. 2022;79(11):1074-1086. doi:10.1016/j.jacc.2021.12.025

Yang J, Zhang Y, Yang S, et al. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis. Thromb J. 2024;22(1):9. doi:10.1186/s12959-024-00608-5

Yao X, Tangri N, Gersh BJ, et al. Oral anticoagulation use in individuals with atrial fibrillation and chronic kidney disease. J Am Coll Cardiol. 2024;83(6):567-582. doi:10.1016/j.jacc.2023.11.031

Zaleski AL, Kolte D, Aronow HD, et al. Anticoagulation for patients with concomitant atrial fibrillation and chronic kidney disease. J Am Heart Assoc. 2023;12(23):e034176. doi:10.1161/ JAHA.123.034176